Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

More News From The World Insiders

Dozens dead or hurt in wedding party blast in Afghan capital

Aug 18, 2019

KABUL, Afghanistan — An explosion ripped through a wedding party on a busy Saturday night in Afghanistan's capital and dozens of people were killed or wounded, a government official said. Hundreds of people were believed to be inside. Interior Ministry spokesman Nusrat Rahimi told The Associated Press there was no immediate information on the cause of the blast. Both the Taliban and a local affiliate of the Islamic State group carry out bloody attacks in the capital. The blast at the Dubai City wedding hall in western Kabul, a part of the city that many in the minority Shiite Hazara...

Crowd of strangers says goodbye to El Paso shooting victim

Aug 18, 2019

EL PASO, Texas — Thousands of strangers from Los Angeles to Tucson have come to El Paso, Texas, to say goodbye to an El Paso shooting victim after hearing that she had few family members. Antonio Basco is scheduled Saturday to bury his long-time companion, 63-year-old Margie Reckard, who was killed by a gunman who opened fire at an El Paso Walmart this month. Attendees waited more than two hours in 100-degree (38 Celsius) temperatures on Friday after Basco invited the public to attend her companion's funeral. Angelique Tadeo of Tucson, Arizona says she and her husband, Paul, and their...

Signs of recession worry Trump ahead of 2020

Aug 18, 2019

WASHINGTON — President Donald Trump is warning of an economic crash if he loses reelection, arguing that even voters who personally dislike him should base their ballots on the nation's strong growth and low unemployment rate. But privately, Trump is growing increasingly worried the economy won't look so good come Election Day. The financial markets signaled the possibility of a U.S. recession this week, sending a jolt of anxiety to investors, companies and consumers. That's on top of concerns over Trump's plans to impose punishing tariffs on goods from China and word from the United Kingdom and Germany that their...

Hundreds arrive to honor El Paso victim after public invited

Aug 18, 2019

EL PASO, Texas — When Jordan Ballard read that one of the victims of the El Paso massacre had few relatives and the public was invited to her funeral, the Los Angeles resident bought a plane ticket and flew to Texas to honor a woman she had never met. She was one of hundreds of strangers who braved 100-degree (38 Celsius) heat to pay their respects to 63-year-old Margie Reckard. Feeling heartbroken and alone after her death, Reckard's companion of 22 years, Antonio Basco, had welcomed anyone to attend. "I arrived here this morning," said Ballard, 38, who lived in...

Java still a no-no for Mormons despite fancy coffee names

Aug 18, 2019

SALT LAKE CITY — The Church of Jesus Christ of Latter-day Saints has issued a warning to members that coffee is prohibited no matter how fancy the name, that vaping is banned despite the alluring flavors and that marijuana is outlawed unless prescribed by "competent" doctors. The new guidance in the August issue of a church youth magazine does not include fundamental changes to the religion's strict health code, but the clarifications are significant and seem to reflect growing concern about young Latter-day Saints' adherence to the rules. The article says it aims to clear up issues that could be...

About Us

The World Insiders brings you exclusive coverage from across the globe in a timely, easy to consume format sourced directly from our regional media partners.

Contact us: sales[at]theworldinsiders.com

Subscribe Now!